Common heart drugs recalled due to contamination with possible carcinogen

Leslie Hanson
July 12, 2018

The Mohap explained that other medicines containing Valsartan manufactured using the same active ingredient from other sources are safe to use.

The valsartan used in the products contains an impurity, N-nitrosodimethylamine (NDMA), a chemical that could potentially cause cancer in humans with long-term exposure, according to the government agency. For example, Swiss company Novartis informed the ministry that their products containing valsartan are not impacted because these products do not contain the ingredient from external suppliers.

Unless alternative medicine is available, patients taking the medicine should continue using it as serious health consequences could result if the medicine is stopped.

Valsartan is used to treat hypertension and can prevent cardiovascular complications associated with the condition.


The recall was issued by the manufacturers of several drugs involving five companies.

As a precautionary measure, the valsartan-containing medications are recalled on a pharmacy level.

Health Canada is advising Canadians taking any valsartan drug to contact their pharmacist and health-care provider to determine what steps to take.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER